Lyme disease in France: A primary care-based prospective study

Epidemiology and Infection

Volumn 133, Issue 5, 2005, Pages 935-942

  Letrilliart, Laurent ^a,c   Ragon, B ^a   Hanslik, T ^b   Flahault, A ^a  

^a INSERM   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c Centre Médical   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGRICULTURAL WORKER; ARTICLE; BACTERIAL TRANSMISSION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DEER; ERYTHEMA CHRONICUM MIGRANS; FEMALE; FRANCE; GENERAL PRACTITIONER; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RURAL AREA;

ADULT; AGE FACTORS; AGRICULTURAL WORKERS' DISEASES; BORRELIA BURGDORFERI; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; INCIDENCE; LYME DISEASE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; RURAL HEALTH;

EID: 26944476943     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268805004413     Document Type: Article

References (36)

1. O'Connell S, Granström M, Gray J, Stanek G. Epidemiology of European Lyme borreliosis. Zentralbl Bakteriol 1998; 287: 229-240.
2. Strle F, Stantic-Pavlinic M. Lyme disease in Europe. N Engl J Med 1996; 334: 803.
3. Lyme disease - United States, 2000. Morb Mortal Wkly Rep 2002; 51: 29-31.
4. Report of WHO workshop on Lyme Borreliosis diagnosis and surveillance. Warsaw, Poland: WHO/CDS/VPH/ 95.141 (1996), 1995.
5. Baranton G, Seinost G, Theodore G, Postic D, Dykhuizen D. Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity. Res Microbiol 2001; 152: 149-156.
6. Colin C, Geffroy L, Maisonneuve H, et al. Country profile. France. Lancet 1997; 349: 791-797.
7. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance: Lyme disease. MMWR Recomm Rep 1997; 46: 20-21.
8. Stanek G, O'Connell S, Cimmino M, et al. European union concerted action on risk assessment in Lyme Borreliosis: Clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741-747.
9. Départment de la démographie, Insee. Population census 1999. Contrasted evolution of the rural area. Insee Première 2000; 726 1-4.
10. er janvier 2000 (http://www.ined.fr/population-en-chiffres/france/population/ tabpyr2000.htm). Accessed 22 February 2005.
11. ONC/FDC-Réseau de correspondants 'Cervidés-Sanglier'. Hunting board Red deer-Roe deer-Wild boars, 1998-1999 season. Bull mensuel de l'Office national de la chasse 1999; 248 (Suppl): 1-4.
12. Caisse Nationale d'Assurance Maladie des Travailleurs Salariés (CNAMTS). Indicateur Statistique. Paris: Caisse Régionale d'Assurance Maladie d'Ile-de-France, 2000.
13. Département de la démographie, Insee. The official population at 1999 census. Insee Première 2000; 691: 1-4.
14. Flahault A, Canard C. Impact of sampling levels on the precision of estimators. In: Schlaud M, ed. Comparison and harmonisation of denominator data from primary health care research in countries of the European Community. Amsterdam: IOS Press, 1999: 34-35.
15. Gardner M, Altman D. Statistics with confidence: Confidence intervals and statistical guidelines. London: BMJ Books, 1989: 116-118.
16. Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995; 333: 1319-1327.
17. Campbell GL, Fritz CL, Fish D, Nowakowski J, Nadelman RB, Wormser GP. Estimation of the incidence of Lyme disease. Am J Epidemiol 1998; 148: 1018-1026.
18. Orloski KA, Hayes EB, Campbell GL, Dennis DT. Surveillance for Lyme disease - United States, 1992-1998. MMWR CDC Surveill Summ 2000; 49: 1-11.
19. Dournon E, Villeminot S, Hubert B. Lyme disease in France: A survey performed in a sentinel network of general practitioners. Bull Epidemiol Hebd 1989; 45: 185-186.
20. Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996; 335: 1270-1274.
21. Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA. Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 697-703.
22. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998; 352: 557-565.
23. Christiann F, Rayet P, Patey O, Lafaix C. Epidemiology of Lyme disease in France: Lyme borreliosis in Ahe region of Berry sud: a six year retrospective. Eur J Epidemiol 1996; 12: 479-483.
24. Kitron U, Kazmierczak JJ. Spatial analysis of the distribution of Lyme disease in Wisconsin. Am J Epidemiol 1997; 145: 558-566.
25. Rath PM, Ibershoff B, Mohnhaupt A, et al. Seroprevalence of Lyme borreliosis in forestry workers from Brandenburg, Germany. Eur J Clin Microbiol Infect Dis 1996; 15: 372-377.
26. Zhioua E, Rodhain F, Binet P, Perez-Eid C. Prevalence of antibodies to Borrelia burgdorferi in forestry workers of Ile de France, France. Eur J Epidemiol 1997; 13: 959-962.
27. Glass GE, Schwartz BS, Morgan III JM, Johnson DT, Noy PM, Israel E. Environmental risk factors for Lyme disease identified with geographic information systems. Am J Public Health 1995; 85: 944-948.
28. Gern L, Estrada-Pena A, Frandsen F, et al. European reservoir hosts of Borrelia burgdorferi sensu lato. Zentralbl Bakteriol 1998; 287: 196-204.
29. Gray JS, Kahl O, Janetzki C, Stein J. Studies on the ecology of Lyme disease in a deer forest in County Galway, Ireland. J Med Entomol 1992; 29: 915-920.
30. Gilot B, Degeilh B, Pichot J, Doche B, Guiguen C. Prevalence of Borrelia burgdorferi (sensu lato) in Ixodes ricinus (L.) populations in France, according to a phytoecological zoning of the territory. Eur J Epidemiol 1996; 12: 395-401.
31. Mannelli A, Cerri D, Buffrini L, et al. Low risk of Lyme borreliosis in a protected area on the Tyrrhenian coast, in central Italy. Eur J Epidemiol 1999; 15: 371-377.
32. Hellwage J, Meri T, Heikkila T, et al. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi J Biol Chem 2001; 276: 8427-8435.
33. American College of Physician. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. American College of Physicians. Ann Intern Med 1997; 127: 1106-1108.
34. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996; 34: 1-9.
35. Centers For Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 1995; 44 590-591.
36. Robertson J, Guy E, Andrews N, et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000; 38: 2097-2102.